| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006059093A3 Fusion proteins |
| 08/17/2006 | WO2006052806A3 Insectidical polypeptides and methods of use thereof |
| 08/17/2006 | WO2006038007A3 Inhibitory analogues to block receptors for microbial pathogenic determinants |
| 08/17/2006 | WO2006031976A3 Compositions and methods for treating stat-6 associated diseases or conditions |
| 08/17/2006 | WO2006031885A3 Kdr and vegf/kdr binding peptides |
| 08/17/2006 | WO2006021896A3 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics |
| 08/17/2006 | WO2006015370A3 Site specific system for generating diversity protein sequences |
| 08/17/2006 | WO2006014673A3 Insulin-oligomer conjugates, formulations and uses thereof |
| 08/17/2006 | WO2006013106A3 Vaccine for prevention and treatment of hiv-infection |
| 08/17/2006 | WO2005114173A3 Hdm2-inhibitor complexes and uses thereof |
| 08/17/2006 | WO2005111072A3 Notch-based fusion proteins and uses thereof |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | WO2005086674A3 Brhf1 as a cancer diagnostic marker |
| 08/17/2006 | WO2005065239A8 Novel recombinant proteins with n-terminal free thiol |
| 08/17/2006 | WO2005049814A3 Novel atypical pneumonia-causing virus |
| 08/17/2006 | WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/17/2006 | WO2005016116A3 Hemostatic devices containing a protein precipitate |
| 08/17/2006 | WO2004104191A8 Crystalline vap-1 and uses thereof |
| 08/17/2006 | WO2004089284A8 Targets for tumor growth inhibition |
| 08/17/2006 | WO2003104391A3 Antibacterial targets in alloiococcus otitidis |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | WO2003066831A3 Angiogenesis genes |
| 08/17/2006 | WO2003062391A3 Structural and cytoskeleton-associated proteins |
| 08/17/2006 | US20060185030 Cytokinin response regulators and uses thereof |
| 08/17/2006 | US20060185028 Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions |
| 08/17/2006 | US20060183894 encoding a humanized green fluorescent protein from Ptilosarcus gurneyi; useful as a fluorescent tag for monitoring the activities of its fusion partners using imaging |
| 08/17/2006 | US20060183888 Pyrrolysine synthesis and modification |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183885 Oncogenic protein for use in identifying modulators which inhibit protein/protein interaction |
| 08/17/2006 | US20060183884 Compounds and methods for modulating cell adhesion |
| 08/17/2006 | US20060183883 C5a Receptor antagonists |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183703 Circular expression construct for gene therapeutic applications |
| 08/17/2006 | US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183689 Activation of peptide prodrugs by hK2 |
| 08/17/2006 | US20060183688 Screening for drugs for treatment of pathologies involving deregulation of apoptosis including autoimmune diseases, neurological disorders and cancers |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183679 Peptides having a high cysteine content |
| 08/17/2006 | US20060183678 Nogo a binding molecules and pharmaceutical use thereof |
| 08/17/2006 | US20060183677 Novel exendin agonist formulations and methods of administration thereof |
| 08/17/2006 | US20060183675 Controlling microorganisms; wound healing products, bandages, medical devices such as, e.g., catheters and further in anti-dandruff hair products |
| 08/17/2006 | US20060183673 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/17/2006 | US20060183672 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma |
| 08/17/2006 | US20060183669 separating two forms of a polypeptide having a single amino acid racemization by eluting the two forms of the polypeptide from an ion exchange chromatography resin under conditions where the salt concentration is increased at a pH that is no more than 1 pH unit from a pKa of X |
| 08/17/2006 | US20060183668 Novel insulin derivatives |
| 08/17/2006 | US20060183666 Method of purifying preproinsulin |
| 08/17/2006 | US20060183665 Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension |
| 08/17/2006 | US20060183232 Packaging cells for recombinant adenovirus |
| 08/17/2006 | US20060183229 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 08/17/2006 | US20060183200 Methods and means relating to protein variants |
| 08/17/2006 | US20060183199 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 08/17/2006 | US20060183198 Methods for expression and purification of recombinant human growth hormone |
| 08/17/2006 | US20060183197 Variant growth hormone molecules conjugated with macromolecules compounds |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183193 Vectors and methods for high throughput co-expression |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060183190 Novel transporter protein |
| 08/17/2006 | US20060183189 Regulatable gene expression in mammalian cells and mammals |
| 08/17/2006 | US20060183187 Gene and polypeptide sequences |
| 08/17/2006 | US20060183177 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 08/17/2006 | US20060183173 for use in immunoassay, replace albumin and casein which are linked to mad cow disease concerns; large scale E coli synthesis; modified DNAk (HSP70) protein |
| 08/17/2006 | US20060183164 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 08/17/2006 | US20060183163 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 08/17/2006 | US20060183162 Novel markers for alternatively activated macrophages |
| 08/17/2006 | US20060183161 IL-ILI gene and polypeptide products |
| 08/17/2006 | US20060183159 Method for engineering a protein by in vitro coevolution |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183137 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 08/17/2006 | US20060183134 Nucleotide sequences coding mutY human homologue (MYH) gene for use as diagnostic tool in detection of colon cancer |
| 08/17/2006 | US20060183133 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 08/17/2006 | US20060183131 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/17/2006 | US20060183125 Diagnostic and prognostic compounds and method |
| 08/17/2006 | US20060183122 Fanc gene mutations in cancer |
| 08/17/2006 | US20060183121 Chimeric autoprocessing polypeptides and uses thereof |
| 08/17/2006 | US20060183120 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers |
| 08/17/2006 | US20060183114 Novel Eosinophil Cationic Proteins used in the Treatement of Asthematic and Allergic Disorders |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182807 Copolymer and hemoprotein based novel compounds and uses thereof |
| 08/17/2006 | US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum |
| 08/17/2006 | US20060182768 Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections |
| 08/17/2006 | US20060182764 Enhancing the effect of vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 08/17/2006 | US20060182762 Enterovirus, vaccines, medicaments and diagnostic kits |
| 08/17/2006 | US20060182761 Methionine salvage pathway in Bacillus |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182756 Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182754 Abundant extracellular products and methods for their production and use |
| 08/17/2006 | US20060182736 Transducible dna-binding proteins |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182714 Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides |
| 08/17/2006 | US20060182684 non-invasive and flexible method and carrier for drug delivery across the blood-brain barrier; brain tumors, brain metastases, stroke, schizophrenia, epilepsy, Alzheimer's, Parkinson's and Huntington's disease |
| 08/17/2006 | DE102005005737A1 New hydrophobin polypeptide not connected in normal manner with an external hydrophobin useful for coating of a glass surfaces |